SUSRF Financials
Surgical Science Sweden AB (publ) - Financial statements & key metrics
Stock Price
$2.84
Market Cap
$150.36M
P/E Ratio
20.3
EPS
$0.14
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$989.85M
Gross Profit
$575.46M
Operating Income
$108.70M
Net Income
$66.65M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$4.68B
Total Liabilities
$417.26M
Shareholders Equity
$4.26B
Cash & Equivalents
$614.88M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$79.59M
CapEx
$11.65M
Free Cash Flow
$67.95M
Profitability Metrics
Gross Margin
66.6%
Net Margin
0.1%
ROE
0.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SUSRF revenue?
SUSRF's most recent quarterly revenue was $989.85M. Annual revenue can be calculated by summing the four most recent quarters.
Is SUSRF profitable?
SUSRF reported a profit of $66.65M in the most recent quarter. The net profit margin is 0.1%.
What is SUSRF market cap?
SUSRF has a market capitalization of $150.36M, making it a small-cap stock.
Does SUSRF have debt?
View SUSRF's balance sheet for debt information.
What is SUSRF cash flow?
SUSRF's most recent quarterly free cash flow was $67.95M.